This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Colorectal squamous cell carcinoma, excluding all cancers (controls excluding all cancers)
C3_COLORECTAL_SQUAM_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
38 |
4. Check minimum number of eventsNone |
38 |
5. Include endpointsNone |
38 |
6. Filter based on genotype QC (FinnGen only) |
38 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Colorectal squamous cell carcinoma, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Colorectal squamous cell carcinoma
- Colorectal cancer
- Colorectal cancer, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 38 | 31 | 7 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | 62.06 | 59.94 | 71.42 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
28
14
73.20
40.23
3.4
1.6
ug/l
2.1
3.6
—
23
9
(3022145) Colonoscopy Study observation
25
31
21.65
21.50
2.8
1.2
—
—
—
0
0
(4035726)
18
9
36.18
14.21
1.4
1.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
17
42
6.51
7.28
2.3
1.8
mmol/l
0.8
0.8
1.11
17
37
(3023368) Bacteria identified in Blood by Culture
20
60
5.93
6.91
6.3
3.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
28
116
6.37
6.60
3.5
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
29
129
6.24
6.22
9.0
3.9
g/l
35.3
36.1
0.37
29
121
(40758558) Short blood count panel - Blood
18
65
4.36
4.66
10.1
4.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
22
93
4.24
4.59
8.4
2.0
mmol/l
2.3
2.4
0.55
22
77
(3033658) Prothrombin time (PT) actual/Normal
17
63
4.07
4.18
3.2
3.3
%
101.1
93.6
0.52
17
63
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
16
7.00
3.93
1.2
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
21
96
3.65
3.73
3.6
2.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
16
62
3.73
3.62
2.6
1.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
29
169
4.01
3.60
11.4
3.3
umol/l
8.0
9.8
2.12
29
155
(3002256) Pathology report gross observation
11
33
4.28
3.50
2.0
1.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
7
11
7.50
3.35
6.1
6.9
mmol/l
24.7
26.0
—
7
11
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
13
47
3.68
3.20
2.5
2.8
e6/l
2.7
5.3
—
7
26
(36304419) Bacteria [Presence] in Urine
17
78
3.13
2.85
3.7
2.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
20
101
3.07
2.85
5.7
6.7
inr
1.0
1.2
—
5
29
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
23
127
3.05
2.78
5.8
3.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
17
81
2.99
2.64
3.1
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
12
53
2.85
2.06
5.0
2.0
mmol/l
2.5
2.4
0.33
12
40
(3037467) Urinalysis macro (dipstick) panel - Urine
30
215
2.87
2.05
5.6
4.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
16
4.24
2.02
1.0
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
9
35
3.05
1.96
2.8
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
23
3.49
1.90
1.7
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
23
3.49
1.90
1.7
1.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
12
4.62
1.88
2.4
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
18
102
2.45
1.88
5.0
5.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
12
56
2.67
1.85
2.1
2.5
e6/l
0.2
1.2
—
6
34
(3014007) Fractional oxyhemoglobin in Arterial blood
5
13
4.25
1.77
6.0
8.7
%
97.4
93.4
—
5
13
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
13
4.25
1.77
9.4
7.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
23
150
2.35
1.71
3.8
5.1
e9/l
1.3
1.8
2.50
18
137
(3006315) Basophils [#/volume] in Blood
23
150
2.35
1.71
3.5
5.1
e9/l
0.0
0.0
1.49
17
134
(3001604) Monocytes [#/volume] in Blood
23
150
2.35
1.71
3.4
5.0
e9/l
0.5
0.5
0.07
17
134
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
5
14
3.94
1.67
6.0
7.9
%
0.9
1.7
—
5
14
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
5
14
3.94
1.67
6.0
7.9
%
0.4
0.8
—
5
14
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
15
3.67
1.57
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
6
21
3.19
1.57
1.0
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
28
2.83
1.54
1.3
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
23
155
2.23
1.53
4.3
5.1
e9/l
0.2
0.2
0.51
18
139
(3021589) Normoblasts [#/volume] in Blood
19
119
2.19
1.51
17.2
8.1
e9/l
0.0
0.0
0.00
13
96
(3002173) Hemoglobin [Mass/volume] in Arterial blood
6
24
2.77
1.36
8.3
6.8
g/l
112.7
123.8
—
6
24
(3001019) Free T4 and TSH panel - Serum or Plasma
5
18
3.04
1.33
1.8
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
19
124
2.06
1.31
2.2
1.8
pmol/l
87.1
99.0
—
10
47
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
73
2.19
1.31
1.9
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
5
19
2.87
1.25
6.4
7.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
21
2.58
1.12
1.6
2.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
7
33
2.37
1.12
1.1
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
16
105
1.90
1.04
4.8
2.1
u/l
57.4
56.2
0.06
16
96
(3003694) ABO and Rh group [Type] in Blood
11
66
1.94
0.90
1.3
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
6
31
2.11
0.89
8.3
6.2
mmol/l
-0.0
2.2
—
6
25
(40760892) CBC W Ordered Manual Differential panel - Blood
10
59
1.94
0.86
4.6
4.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
27
0.00
0.81
0.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
27
311
0.54
0.79
3.7
6.2
mmol/mol
37.0
40.4
2.25
22
292
(3048689) Calprotectin [Mass/mass] in Stool
7
42
1.81
0.73
1.3
1.6
ug/g
92.9
106.3
—
7
34
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
28
1.90
0.69
1.4
2.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
15
108
1.64
0.67
2.5
2.8
u/l
24.3
29.1
0.72
15
101
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
19
0.00
0.62
0.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
19
0.00
0.62
0.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
35
1.84
0.61
1.0
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
33
300
1.76
0.53
22.7
12.4
%
37.9
39.7
1.26
26
217
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
16
0.00
0.42
0.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
21
178
1.40
0.39
3.1
2.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
29
263
1.43
0.34
33.6
13.8
%
13.8
13.6
0.53
29
257
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7
54
1.36
0.33
1.6
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
31
325
0.75
0.32
3.9
4.8
mmol/l
5.7
5.9
0.93
26
300
(3013826) Glucose [Moles/volume] in Serum or Plasma
20
172
1.34
0.31
7.0
3.9
mmol/l
6.6
6.7
0.09
20
157
(3013512) EKG study
11
86
1.39
0.30
3.6
3.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
13
105
1.36
0.30
1.4
2.0
u/l
95.8
115.0
0.25
13
99
(3041096) Erythrocytes [Presence] in Urine by Automated
11
87
1.37
0.28
3.9
3.7
—
—
—
0
0
(3020891) Body temperature
0
11
0.00
0.22
0.0
3.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
11
0.00
0.22
0.0
3.6
—
1.2
—
0
11
(40768443) Skin Pathology biopsy report
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(1002224) Polysomnography panel
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
6
74
0.78
0.17
1.3
1.2
g/l
2.0
2.4
—
6
40
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
9
78
1.20
0.17
1.4
1.8
mg/l
3.6
0.7
—
9
69
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
29
301
0.85
0.17
4.6
5.0
mu/l
2.0
1.9
0.13
24
276
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
13
116
1.18
0.11
3.5
4.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
12
134
0.85
0.11
2.6
2.3
nmol/l
74.7
78.8
0.19
12
119
(3044889) 12 lead EKG panel
24
229
1.13
0.06
4.0
3.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
10
110
0.88
0.06
1.9
3.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
10
95
1.07
0.00
4.4
2.9
—
—
—
0
0
(3015736) pH of Urine
11
108
1.03
0.00
2.5
3.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
2.3
—
4.0
—
0
6
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
8
83
0.95
0.00
1.4
2.3
umol/l
30991.3
11073.0
—
8
70
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
2.3
—
106.2
—
0
6
(3022313) Gas panel - Capillary blood
0
6
0.00
0.00
0.0
6.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.4
—
1.4
—
0
7
(3038515) Glucose [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.4
—
8.3
—
0
7
(4027681)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
6
64
0.93
0.00
2.7
3.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
0
7
0.00
0.00
0.0
5.0
—
25.1
—
0
7
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
66.8
—
0
9
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
5
58
0.84
0.00
1.2
1.4
—
675.6
—
0
18
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_COLORECTAL_SQUAM_EXALLC – Colorectal squamous cell carcinoma, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).